论文部分内容阅读
目的:探讨乳腺癌保乳术后不同放疗方式的临床疗效,并观察不同放疗方式的不良反应。方法:选择106例接受乳腺癌保乳术治疗的患者,随机分为观察组(同步推量放疗组,n=62)与对照组(常规放疗组,n=44),随访1年统计生存率与复发率,评估不良反应情况。结果:观察组末次随访生存率为100.0%,均无瘤生存,明显高于对照组,有1例同侧胸壁复发,复发率低于对照组,在不良反应方面,急性放射性皮肤反应及远期不良反应发生率均明显低于对照组,组间比较存在显著统计学差异(P<0.05)。结论:乳腺癌保乳术后同步推量放疗有利于提高患者生存率,减少局部复发,不良反应少,可在乳腺癌患者中推广应用。
Objective: To investigate the clinical effects of different radiotherapy methods after breast-conserving surgery and to observe the adverse reactions of different radiotherapy methods. Methods: A total of 106 patients undergoing conservative breast-conserving surgery were enrolled in this study. Patients were randomly divided into observation group (n = 62) and control group (n = 44) Relapse rate, assessment of adverse reactions. Results: The last follow-up survival rate of the observation group was 100.0%, no tumor-free survival was significantly higher than the control group, there was a case of ipsilateral chest wall recurrence, the recurrence rate was lower than the control group, adverse reactions, acute radiation skin reaction and long-term Adverse reactions were significantly lower than the control group, there were significant statistical differences between groups (P <0.05). Conclusion: Breast breast conserving surgery synchronized push radiotherapy is conducive to improving patient survival, reduce local recurrence, fewer adverse reactions, can be applied in patients with breast cancer.